Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 25Breast Neoplasms 22Salivary Gland Neoplasms 3Prostate Adenocarcinoma 2Neoplasm Metastasis 2Breast Neoplasms, Male 2Triple Negative Breast Neoplasms 1Stage I Prostate Adenocarcinoma AJCC v7 1Sexual Dysfunctions, Psychological 1Primary Dysautonomias 1Patient Compliance 1PSA Level Greater Than Two 1Kidney Diseases 1Hypertension 1Hormone Sensitive Prostate Cancer 1Hereditary Sensory and Autonomic Neuropathies 1HER2-positive Breast Cancer 1HER2 Negative Breast Cancer 1Castrate Sensitive Prostate Cancer 1Bulbo-Spinal Atrophy, X-Linked 1Anatomic Stage I Breast Cancer AJCC v8 1Advanced Breast Cancer 1

Interventions

regorafenib 1beta-Aminoethyl Isothiourea 1Surveys and Questionnaires 1Standard of Care 1Specimen Handling 1Self Care 1Ocoxin 1Nutrition Assessment 1Motivational Interviewing 1Leuprolide 1Goserelin 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Patient Compliance × Goserelin × 1 year × Clear all
NCT05122377 2026-01-06

RWE About QOL and Compliance of Patients With OFS in China

Fudan University

Completed
562 enrolled
Breast

Breast Neoplasms, Patient Compliance

Data powered by HemOnc (CC BY 4.0) Colophon âš¡